Discharge to Assess Community Beds
NHS Bristol, North Somerset and South Gloucestershire ICB ("the Commissioner") sought to commission the block provision of Pathway 3 (P3) Discharge to Assess Beds for patients requiring intensive, bed‑based rehabilitation following hospital admission. Pathway 3 supports people who require approximately 28 days of intensive rehabilitation in a community hospital or nursing/residential care home setting and who are expected to require a long‑term care package, most likely in a nursing or residential care home. BNSSG ICB has implemented a Discharge to Assess model in collaboration with ICS partners, incorporating four pathways (0-3) to support timely discharge from hospital and maximise independence. Pathway 3 forms part of this wider system. The Commissioner has followed PSR Direct Award Process C for the award of this contract. The total expected value of the contract for the initial 18-month contract term is £596,955.07 excluding VAT. The optional 12-month extension expected value of the contract is £398,707.13 excluding VAT. Therefore, the full expected lifetime contract value (18-month + optional 12-month extension) is £995,662.20 excluding VAT. The contract value stated is exclusive of VAT. The services being procured constitute VAT-exempt welfare services provided by a registered care home The contract period will commence on 1st April 2026. This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.